Status:
COMPLETED
Subsyndromal Delirium in Intensive Care Unit
Lead Sponsor:
Centro Hospitalar Lisboa Ocidental
Collaborating Sponsors:
Orion Corporation, Orion Pharma
Conditions:
Delirium
Eligibility:
All Genders
18-100 years
Brief Summary
Subsyndromal delirium (SSD) is a condition characterized by a less severe cognitive impairment in comparison to delirium. To date there is no published consensus on SSD definitions and has been common...
Detailed Description
SubSynD is a prospective, observational, multicenter clinical study, involving 400 patients in Intensive Care Units, to assess subsyndromal delirium. A systematic screening for delirium and subsyndro...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Admission in Intensive care Unit
Exclusion
- Primary neurological diagnosis, with Glasgow Coma Scale (GCS) \<14 on ICU admission or in previous days;
- Blindness or deafness;
- Aphasia;
- Inability to communicate in the native language of the country where the study is enrolled;
- Death during the first 24 hours;
- Limitation of therapeutic efforts in the Intensive Care Unit admission;
- Refusal to participate;
- Previous diagnosis of dementia or psychiatric illness;
- Readmission in ICU;
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03813459
Start Date
August 1 2018
End Date
March 31 2020
Last Update
December 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria Carolina Vieira Júlio Paulino
Lisbon, Portugal, 1300-346